Qinlock 50 mg (Ripretinib TABLET) 50 MG

QINLOCK 50 MG tablets contain ripretinib, a medication used to manage certain health conditions. Learn about its uses, effects, and precautions here.

Strength

50 MG

Manufacturer / TM Owner

DECIPHERA PHARMACEUTICALS. LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

QINLOCK 50 MG tablets are primarily used for the treatment of advanced gastrointestinal stromal tumors (GIST). Ripretinib, the active ingredient, works by targeting specific proteins involved in tumor growth. This medication is often prescribed when other treatments have not been effective. Patients may wonder, 'What is QINLOCK used for?' and the answer lies in its role in managing specific types of cancer.

Side Effects

Common effects of QINLOCK 50 MG tablets may include fatigue, nausea, and abdominal pain. Some users might experience changes in taste or hair color. These effects can vary from person to person, and it's important to monitor any unusual symptoms. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

QINLOCK 50 MG tablets should be handled with care. Store them at room temperature away from moisture and heat. Keep the medication out of reach of children and pets. Follow the prescribed dosage and administration instructions provided by your healthcare provider. Do not share this medication with others.

Avoid Interactions

QINLOCK 50 MG tablets may interact with certain medications, including those metabolized by the liver's CYP3A4 enzyme. Alcohol and other substances that affect liver function could also impact the effectiveness of ripretinib. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.

References

Frequently Asked Questions

QINLOCK 50 MG tablets are used to treat advanced gastrointestinal stromal tumors (GIST) in patients who have received prior treatment.

QINLOCK 50 MG tablets are taken orally, typically once daily. Follow the specific instructions provided by your healthcare provider.

Common side effects may include fatigue, nausea, abdominal pain, changes in taste, and hair color changes.

It is advisable to avoid alcohol while taking QINLOCK 50 MG tablets, as it may interact with the medication.

QINLOCK 50 MG tablets can be purchased from authorized online pharmacies. Ensure you are buying from a reputable source.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.